Cantor Fitzgerald upgraded Allscripts (NASDAQ: MDRX) from Neutral to Overweight with a price target of $17.00 (from $15.00).Analyst Steven Halper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE